Rockwell Medical (RMTI) Short term Debt (2013 - 2026)

Rockwell Medical (RMTI) has reported Short term Debt for 8 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt fell 29.28% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (down 29.28% YoY), and the FY2025 full-year result was $1.0 million, down 57.82% from the prior year.
• Short term Debt climbed to $1.8 million in Q2 2026 per RMTI's latest filing, from $707000.0 in the prior quarter.
• Across five years, Short term Debt topped out at $6.6 million in Q1 2022 and bottomed at $707000.0 in Q1 2026.
• Historically, Short term Debt has averaged $3.0 million across 5 years, with a median of $2.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Short term Debt plunged 77.9% in 2022, then surged 53.28% in 2023.
• Over 5 years, Short term Debt stood at $1.6 million in 2022, then soared by 53.28% to $2.5 million in 2023, then declined by 5.16% to $2.4 million in 2024, then sank by 57.82% to $1.0 million in 2025, then jumped by 76.8% to $1.8 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $1.8 million, $707000.0, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.